OBJECTIVE: The present study was designed to test the hypothesis that airway epithelial cell (AEC) mediator release is similar in upper and lower airway AEC in children. METHODS: Nasal and bronchial AEC were collected by brushings from children scheduled for general anesthetic. AEC release of the following mediators was measured: interleukin (IL)-6, IL-8, Granulocyte Colony Stimulating Factor (G-CSF), regulated on activation, normal T-cell expressed and secreted (RANTES), monocyte chemoattractant protein-1 (MCP-1), vascular endothelial growth factor (VEGF), matrix metallo proteinase (MMP)-9, and tissue inhibitor of metalloproteinases (TIMP)-1. RESULTS: AEC were cultured in 34 children, mean age 7.3 years. Release of IL-6, IL-8, and G-CSF was significantly higher in nasal compared with bronchial AEC but nasal and bronchial AEC release of other mediators was not significantly different. Treatment of AEC with IL-1 β and tumor necrosis factor-α increased secretion of all mediators. Release of IL-6 and GSCF remained higher in nasal AEC compared with bronchial AEC following stimulation. CONCLUSIONS: In epidemiological studies, nasal AEC may be a useful surrogate for bronchial AEC for the study of RANTES, MCP-1, TIMP-1, and MMP-9 release in children but bronchial AEC will remain the gold standard.
OBJECTIVE: The present study was designed to test the hypothesis that airway epithelial cell (AEC) mediator release is similar in upper and lower airway AEC in children. METHODS: Nasal and bronchial AEC were collected by brushings from children scheduled for general anesthetic. AEC release of the following mediators was measured: interleukin (IL)-6, IL-8, Granulocyte Colony Stimulating Factor (G-CSF), regulated on activation, normal T-cell expressed and secreted (RANTES), monocyte chemoattractant protein-1 (MCP-1), vascular endothelial growth factor (VEGF), matrix metallo proteinase (MMP)-9, and tissue inhibitor of metalloproteinases (TIMP)-1. RESULTS: AEC were cultured in 34 children, mean age 7.3 years. Release of IL-6, IL-8, and G-CSF was significantly higher in nasal compared with bronchial AEC but nasal and bronchial AEC release of other mediators was not significantly different. Treatment of AEC with IL-1 β and tumor necrosis factor-α increased secretion of all mediators. Release of IL-6 and GSCF remained higher in nasal AEC compared with bronchial AEC following stimulation. CONCLUSIONS: In epidemiological studies, nasal AEC may be a useful surrogate for bronchial AEC for the study of RANTES, MCP-1, TIMP-1, and MMP-9 release in children but bronchial AEC will remain the gold standard.
Authors: Steve Turner; Adnan Custovic; Peter Ghazal; Jonathan Grigg; Mindy Gore; John Henderson; Clare M Lloyd; Ben Marsland; Ultan F Power; Graham Roberts; Sejal Saglani; Jurgen Schwarze; Michael Shields; Andrew Bush Journal: Wellcome Open Res Date: 2018-05-17
Authors: M Dutot; S Grassin-Delyle; H Salvator; M Brollo; P Rat; R Fagon; E Naline; P Devillier Journal: Int J Biol Macromol Date: 2019-02-20 Impact factor: 6.953
Authors: Surendran Thavagnanam; Jeremy C Parker; Michael E McBrien; Grzegorz Skibinski; Michael D Shields; Liam G Heaney Journal: PLoS One Date: 2014-01-27 Impact factor: 3.240
Authors: Thamires Marques de Lima; Cristiane Mayumi Kazama; Andreas Rembert Koczulla; Pieter S Hiemstra; Mariangela Macchione; Ana Luisa Godoy Fernandes; Ubiratan de Paula Santos; Maria Lucia Bueno-Garcia; Dirce Maria Zanetta; Carmen Diva Saldiva de André; Paulo Hilario Nascimento Saldiva; Naomi Kondo Nakagawa Journal: Clinics (Sao Paulo) Date: 2013-12 Impact factor: 2.365
Authors: Neil McInnes; Matthew Davidson; Alison Scaife; David Miller; Daniella Spiteri; Tom Engelhardt; Sean Semple; Graham Devereux; Garry Walsh; Steve Turner Journal: Int J Environ Res Public Health Date: 2016-03-24 Impact factor: 3.390
Authors: David Miller; Steve W Turner; Daniella Spiteri-Cornish; Neil McInnes; Alison Scaife; Peter J Danielian; Graham Devereux; Garry M Walsh Journal: PLoS One Date: 2013-11-04 Impact factor: 3.240